Opto Circuits (India) Ltd
Incorporated in 1992, Opto Circuits (India) Ltd
is engaged in the manufacturing and trading of invasive and non-invasive medical equipment.
- Market Cap ₹ 54.1 Cr.
- Current Price ₹ 1.80
- High / Low ₹ /
- Stock P/E 2.18
- Book Value ₹ -4.08
- Dividend Yield 0.00 %
- ROCE 5.68 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of -65.4% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
603 | 670 | 699 | 263 | 146 | 77 | 50 | 63 | 105 | 63 | 8 | 0 | |
362 | 390 | 423 | 148 | 93 | 53 | 35 | 43 | 63 | 46 | 12 | 18 | |
Operating Profit | 242 | 279 | 276 | 115 | 53 | 23 | 15 | 20 | 42 | 17 | -4 | -17 |
OPM % | 40% | 42% | 39% | 44% | 36% | 31% | 30% | 32% | 40% | 27% | -45% | -6,924% |
36 | 1 | -2 | -2 | -187 | 0 | -362 | 0 | 3 | -1,204 | 2 | -141 | |
Interest | 25 | 37 | 22 | 54 | 58 | 32 | 8 | 1 | 1 | 1 | 0 | 0 |
Depreciation | 6 | 6 | 7 | 8 | 10 | 10 | 9 | 9 | 9 | 3 | 1 | 0 |
Profit before tax | 247 | 238 | 245 | 52 | -201 | -18 | -364 | 10 | 35 | -1,192 | -3 | -159 |
Tax % | 1% | 1% | 2% | 18% | 0% | 3% | 0% | 0% | 0% | 0% | 0% | 0% |
244 | 235 | 241 | 42 | -202 | -18 | -364 | 10 | 35 | -1,192 | -3 | -159 | |
EPS in Rs | 10.09 | 9.69 | 9.95 | 1.74 | -8.32 | -0.74 | -15.02 | 0.35 | 1.16 | -39.63 | -0.09 | -5.28 |
Dividend Payout % | 34% | 31% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -55% |
5 Years: | -65% |
3 Years: | -87% |
TTM: | -97% |
Compounded Profit Growth | |
---|---|
10 Years: | -20% |
5 Years: | 80% |
3 Years: | -11% |
TTM: | 651% |
Stock Price CAGR | |
---|---|
10 Years: | -22% |
5 Years: | -9% |
3 Years: | -12% |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 186 | 242 | 242 | 242 | 242 | 242 | 242 | 288 | 301 | 301 | 301 | 301 |
Reserves | 876 | 971 | 1,212 | 1,254 | 1,043 | 1,025 | 650 | 836 | 876 | -262 | -264 | -423 |
724 | 657 | 814 | 881 | 887 | 710 | 714 | 549 | 530 | 489 | 478 | 482 | |
257 | 135 | 207 | 146 | 253 | 282 | 96 | 102 | 118 | 131 | 106 | 68 | |
Total Liabilities | 2,044 | 2,006 | 2,475 | 2,524 | 2,424 | 2,258 | 1,702 | 1,774 | 1,824 | 659 | 620 | 428 |
79 | 74 | 121 | 113 | 95 | 85 | 78 | 69 | 60 | 12 | 11 | 11 | |
CWIP | 1 | 1 | 1 | 1 | 0 | 102 | 102 | 157 | 158 | 0 | 0 | 0 |
Investments | 1,114 | 382 | 382 | 382 | 382 | 382 | 382 | 437 | 447 | 202 | 202 | 20 |
849 | 1,549 | 1,971 | 2,028 | 1,948 | 1,689 | 1,141 | 1,112 | 1,159 | 445 | 407 | 397 | |
Total Assets | 2,044 | 2,006 | 2,475 | 2,524 | 2,424 | 2,258 | 1,702 | 1,774 | 1,824 | 659 | 620 | 428 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
118 | -30 | -93 | -16 | 56 | 335 | 57 | 47 | 42 | 21 | -5 | -3 | |
-572 | 146 | -19 | -0 | 0 | -49 | -56 | -1 | -11 | 19 | 2 | -2 | |
461 | -188 | 69 | 16 | -56 | -285 | -4 | -46 | -30 | -41 | 2 | 5 | |
Net Cash Flow | 7 | -72 | -43 | 0 | -1 | 1 | -2 | 0 | 0 | -1 | 0 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 138 | 140 | 305 | 854 | 1,613 | 4 | 39 | 69 | 81 | 139 | 179 | 0 |
Inventory Days | 265 | 266 | 336 | 1,341 | 1,943 | 3,660 | 2,459 | 394 | 237 | 475 | 1,149 | 470 |
Days Payable | 6 | 12 | 52 | 114 | 670 | 1,827 | 173 | 292 | 289 | 792 | 4,188 | 775 |
Cash Conversion Cycle | 397 | 395 | 589 | 2,082 | 2,887 | 1,837 | 2,324 | 171 | 29 | -179 | -2,860 | -305 |
Working Capital Days | 256 | 657 | 913 | 2,596 | 4,194 | 1,289 | 620 | -9 | -9 | -81 | -1,820 | -23,667 |
ROCE % | 19% | 15% | 13% | 5% | 2% | 1% | 0% | 1% | 2% | 1% | -1% | 6% |
Documents
Announcements
-
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
3 May - Non-submission of Corporate Governance Report due to insolvency.
-
Corporate Insolvency Resolution Process (CIRP)-Filing of Resolution plan with Tribunal
3 May - Approval of resolution plan under insolvency process.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
29 Apr - Update on Corporate Insolvency Resolution Process.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
7 Mar - Approval for extension of CIRP period by 30 days.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
9 Feb - Approval of resolution plans by CoC members.
Annual reports
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
Business Profile:[1]
Company is a multinational medical device organization based in Bengaluru. Company designs, develops, manufactures, markets
and distributes medical products that are
used by healthcare establishments in 150+ countries. Company specializes in vital signs monitoring, emergency cardiac care, vascular treatments, sensing technologies, etc.